Prostate Cancer Diagnosis

CHF 227.95
Auf Lager
SKU
BJSP3UKKLG4
Stock 1 Verfügbar
Geliefert zwischen Do., 30.04.2026 und Fr., 01.05.2026

Details

This new edition presents new perspectives and technologies. It details substantial developments in techniques and complications. It also presents new data on the controversial issue of PSA screening and thresholds as indication to perform biopsy.

Chapters authored by a complete spectrum of specialists

Provides many new perspectives and technologies

Based on the highly successful first edition

Presents new data on controversial issues of screening


Chapters authored by a complete spectrum of specialists Provides many new perspectives and technologies Based on the highly successful first edition Presents new data on controversial issues of screening Includes supplementary material: sn.pub/extras

Inhalt
Ch.1: Defining the Problem.- Ch.2: Prostate Cancer Screening: Navigating the Controversy.- Ch.3: Is the PSA Era Over?.- Ch.4: PSA Dynamics.- Ch.5: Percent Free PSA.- Ch.6: PCA3 and other Urinary Markers.- Ch.7: Blood-Based Tumor Markers for Prostate Cancer.- Ch.8: Prediction Models in Prostate Cancer Diagnosis and Preparation for Biopsy.- Ch.9: Is There a Role for Medications to Reduce the Need for Prostate Biopsy?.- Ch.10: Indications For Initial Biopsy: Is The PSA Threshold Over?.- Ch.11: Preparation for Prostate Biopsy.- Ch.12: Pain Prevention.- Ch.13: Prostate Biopsy.- Ch.14: Prostate Biopsy Techniques.- Ch.15: Transperineal Biopsy.- Ch.16: Pathological Implications of Prostate Biopsy.- Ch.17: Complications of Transrectal Ultrasound Guided Prostate Biopsy.- Ch.18: After the Biopsy: Management of High Grade Prostatic Intraepithelial Neoplasia (HGPIN).- Ch.19: Atypical Small Acinar Proliferation.- Ch.20: Repeat Prostate Biopsy Strategies Indications and Techniques.- Ch.21: Transperineal Mapping Biopsy of the Prostate for Assessment of the Minimal Risk Patient.- Ch.22: Management of the Patient Following a Negative Biopsy: Saturation Biopsy.- Ch.23: Role of imaging as an adjunct or replacement for biopsy: American Experience.- Ch.24: Role Of Imaging As An Adjunct Or Replacement For Biopsy: European Experience.- Ch.25: Prostate Cancer Detection: Lessons Learnt in the Cleveland Clinic Experience with Focus on the Negative Biopsy.- Ch.26: Future Directions in Prostate Cancer Diagnosis.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Editor J. Stephen Jones
    • Titel Prostate Cancer Diagnosis
    • Veröffentlichung 14.11.2012
    • ISBN 1627031871
    • Format Fester Einband
    • EAN 9781627031875
    • Jahr 2012
    • Größe H260mm x B183mm x T25mm
    • Untertitel PSA, Biopsy and Beyond
    • Gewicht 947g
    • Auflage 2013
    • Genre Medizin
    • Lesemotiv Verstehen
    • Anzahl Seiten 400
    • Herausgeber Humana Press
    • GTIN 09781627031875

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38